CHUGAI PHARMACEUTICAL CO., LTD |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,014 JPY | +0.97% |
|
+1.33% | -6.18% |
| May. 14 | Japan's Nikkei drifts sideways as more earnings, US CPI awaited | RE |
| May. 01 | Chugai Pharmaceutical Allots 594 Million Yen Worth of Shares as Restricted Stock Compensation | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 1,091B 7.02B | Sales 2025 * | 1,134B 7.29B | Capitalization | 8,171B 52.55B |
|---|---|---|---|---|---|
| Net income 2024 * | 346B 2.23B | Net income 2025 * | 368B 2.37B | EV / Sales 2024 * | 6.72 x |
| Net cash position 2024 * | 838B 5.39B | Net cash position 2025 * | 1,004B 6.46B | EV / Sales 2025 * | 6.32 x |
| P/E ratio 2024 * |
23.7
x | P/E ratio 2025 * |
22.2
x | Employees | 7,604 |
| Yield 2024 * |
1.7% | Yield 2025 * |
1.8% | Free-Float | 38.08% |
More Fundamentals
* Assessed data
More news
Latest transcript on Chugai Pharmaceutical Co., Ltd
More recommendations
More press releases
| 1 day | +0.66% | ||
| 1 week | +1.52% | ||
| Current month | -1.01% | ||
| 1 month | -2.57% | ||
| 3 months | -15.33% | ||
| 6 months | +5.13% | ||
| Current year | -6.42% |
1 week
4 687.00
5 007.00
1 month
4 687.005 376.00
Current year
4 687.006 697.00
1 year
3 581.006 697.00
3 years
3 191.006 697.00
5 years
2 296.676 697.00
10 years
878.676 697.00
| Managers | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 61 | 87-03-31 |
Junichi Nezu
CTO | Chief Tech/Sci/R&D Officer | - | - |
Hisafumi Okabe
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Masayuki Oku
BRD | Director/Board Member | 79 | 15-02-28 |
Motoo Ueno
BRD | Director/Board Member | 66 | 84-03-31 |
James H. Sabry
BRD | Director/Board Member | 65 | 19-02-28 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 6.57% | 19 M€ | +10.55% | ||
| 1.87% | 57 M€ | +16.55% | ||
| 1.59% | 4 M€ | +17.30% | ||
| 1.53% | 64,792 M€ | +16.39% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-16 | 5,014 | +0.97% | 802 300 |
| 24-05-16 | 4,966 | +2.96% | 3,057,900 |
| 24-05-15 | 4,823 | +0.52% | 2,316,200 |
| 24-05-14 | 4,798 | -3.38% | 5,633,700 |
| 24-05-13 | 4,966 | +0.40% | 1,363,100 |
Delayed Quote Japan Exchange, May 16, 2024 at 08:20 pm EDT
More quotes
Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%).
Net sales are distributed geographically as follows: Japan (74,3%), Switzerland (22,8%) and other (2,9%).
Sector
Pharmaceuticals
Calendar
2024-06-26
- Ex-dividend day for interim dividend
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
4,966
JPY
Average target price
6,021
JPY
Spread / Average Target
+21.25%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -6.42% | 51.25B | |
| +32.36% | 709B | |
| +30.77% | 595B | |
| -1.60% | 367B | |
| +20.07% | 334B | |
| +6.04% | 289B | |
| +14.77% | 239B | |
| +9.13% | 211B | |
| -3.97% | 203B | |
| +9.27% | 171B |
- Stock Market
- Equities
- 4519 Stock